- ISIN
- US62827M7065
- CUSIP
- 62827M706
- Issuer
- Eventide Funds
- Inception Date
- Dec 26, 2012
- Category
- Health & Biotech Equities
- Min. Investment
- $100,000
- Distribution Policy
- Accumulating
- Asset Class
- Equity
- Asset Class Size
- Small-Cap
- Asset Class Style
- Growth
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ETIHX Performance Chart
Eventide Healthcare & Life Sciences Fund (ETIHX) is down 1.1% since the beginning of the year. ETIHX is currently trading at $52 per share. Investors who bought $1,000 worth of ETIHX shares 5 years ago would now be looking at an investment worth $1,180.
Loading charts...
Returns By Period
Eventide Healthcare & Life Sciences Fund (ETIHX) has returned -1.06% so far this year and 53.33% over the past 12 months. Over the last ten years, ETIHX has had an annualized return of 13.36%, just under the S&P 500 Index benchmark’s 13.88%.
Eventide Healthcare & Life Sciences Fund
- 1D
- 1.28%
- 1M
- 0.76%
- YTD
- -1.06%
- 6M
- -3.03%
- 1Y
- 53.33%
- 3Y*
- 10.05%
- 5Y*
- 3.37%
- 10Y*
- 13.36%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ETIHX Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 2013, ETIHX's average daily return is +0.07%, while the average monthly return is +1.46%. At this rate, an investment would double in approximately 4.0 years.
Historically, 61% of months were positive and 39% were negative. The best month was Nov 2019 with a return of +23.7%, while the worst month was Jan 2016 at -27.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ETIHX closed higher 53% of trading days. The best single day was Aug 23, 2021 with a return of +9.4%, while the worst single day was Mar 16, 2020 at -12.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.94% | 0.70% | -3.52% | 5.23% | 0.06% | -1.38% | -1.06% | ||||||
| 2025 | 7.94% | -4.68% | -9.61% | 3.30% | -1.22% | 7.92% | 4.87% | 10.33% | 5.10% | 13.18% | 13.31% | -1.86% | 56.73% |
| 2024 | -2.57% | 7.76% | -0.23% | -12.35% | 0.59% | -0.26% | 8.51% | 0.84% | -2.20% | -1.15% | 1.94% | -9.52% | -10.13% |
| 2023 | 6.36% | -2.23% | -5.36% | 7.13% | 4.04% | 3.09% | 0.13% | -6.36% | -5.77% | -9.37% | 4.11% | 17.75% | 11.01% |
| 2022 | -18.54% | -3.76% | -2.06% | -15.82% | -3.66% | 4.92% | 7.93% | 9.64% | -3.80% | 1.88% | 1.18% | 4.84% | -19.62% |
| 2021 | -4.51% | 3.93% | -6.87% | -0.84% | -7.85% | 0.38% | -4.95% | 10.09% | -0.35% | 1.04% | -9.06% | 2.33% | -16.87% |
Benchmark Metrics
Eventide Healthcare & Life Sciences Fund has an annualized alpha of 4.06%, beta of 1.01, and R2 of 0.36 versus S&P 500 Index. Calculated based on daily prices since January 02, 2013.
- This fund captured 117.00% of S&P 500 Index gains and 111.66% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.36 means the benchmark explains less than half of this fund's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 4.06%
- Beta
- 1.01
- R²
- 0.36
- Upside Capture
- 117.00%
- Downside Capture
- 111.66%
Expense Ratio
ETIHX has a high expense ratio of 1.30%, indicating above-average management fees.
Return for Risk
Risk / Return Rank
ETIHX ranks 69 for risk / return — better than 69% of mutual funds on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Eventide Healthcare & Life Sciences Fund (ETIHX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ETIHX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.20 | ||
| Sortino ratioReturn per unit of downside risk | +0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.37 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 4.30 | 2.78 | +1.52 |
| Martin ratioReturn relative to average drawdown | 12.95 | 12.44 | +0.51 |
Dividends
Dividend History
Eventide Healthcare & Life Sciences Fund provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.47 | $1.94 | $0.87 | $1.98 | $0.37 | $0.00 | $0.29 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.78% | 3.49% | 2.08% | 7.33% | 1.28% | 0.00% | 1.22% |
Monthly Dividends
The table displays the monthly dividend distributions for Eventide Healthcare & Life Sciences Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.47 | $4.47 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Eventide Healthcare & Life Sciences Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Eventide Healthcare & Life Sciences Fund was 55.11%, occurring on May 9, 2022. Recovery took 893 trading sessions.
The current Eventide Healthcare & Life Sciences Fund drawdown is 4.71%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -55.11%May 2022 | 1y 2mo | 3y 6mo | 4y 9moFeb 2021 - Nov 2025 |
2016 bear market2016 | -43.93%Feb 2016 | 6mo 24d | 1y 7mo | 2y 2moJul 2015 - Sep 2017 |
COVID crash2020 | -36.33%Mar 2020 | 1mo 27d | 2mo 12d | 4mo 9dJan 2020 - May 2020 |
Rate-hike selloffLate 2018 | -31.47%Dec 2018 | 2mo 24d | 2mo 19d | 5mo 13dOct 2018 - Mar 2019 |
2014 bear market2014 | -27.88%May 2014 | 2mo 9d | 7mo 5d | 9mo 14dFeb 2014 - Dec 2014 |
Drawdown Indicators
| ETIHX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.11% | -56.78% | +1.67% |
Max Drawdown (1Y)Largest decline over 1 year | -12.50% | -9.10% | -3.40% |
Max Drawdown (3Y)Largest decline over 3 years | -33.23% | -18.90% | -14.33% |
Max Drawdown (5Y)Largest decline over 5 years | -49.27% | -25.43% | -23.84% |
Max Drawdown (10Y)Largest decline over 10 years | -55.11% | -33.92% | -21.19% |
Current DrawdownCurrent decline from peak | -4.71% | -1.80% | -2.91% |
Average DrawdownAverage peak-to-trough decline | -17.95% | -10.71% | -7.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.14% | 2.03% | +2.11% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with ETIHX
Add Eventide Healthcare & Life Sciences Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ETIHX